Attached files
file | filename |
---|---|
EX-32.2 - EXHIBIT 32.2 CFO 906 CERT FY2020 - BOSTON SCIENTIFIC CORP | exhibit322-cfo906202010xk.htm |
EX-32.1 - EXHIBIT 32.1 CEO 906 CERT FY2020 - BOSTON SCIENTIFIC CORP | exhibit321-ceo906202010xk.htm |
EX-31.2 - EXHIBIT 31.2 CFO 302 CERT FY2020 - BOSTON SCIENTIFIC CORP | exhibit312-cfo302202010xk.htm |
EX-31.1 - EXHIBIT 31.1 CEO 302 CERT FY2020 - BOSTON SCIENTIFIC CORP | exhibit311-ceo302202010xk.htm |
EX-21 - EXHIBIT 21 FY2020 LIST OF SUBSIDIARIES DATED JAN 31, 2021 - BOSTON SCIENTIFIC CORP | exhibit21-listofsubsidiari.htm |
EX-4.2 - EXHIBIT 4.2 DESCRIPTION OF REGISTERED SECURITIES FY2020 - BOSTON SCIENTIFIC CORP | exhibit42-descriptionofthe.htm |
10-K - 10-K - BOSTON SCIENTIFIC CORP | bsx-20201231.htm |
EXHIBIT 23
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1) Registration Statement (Form S-3 Nos. 333-238526, 333-76346, 333-61994, and 333-64991) of Boston Scientific Corporation,
(2) Registration Statement (Form S-4 Nos. 333-131608 and 333-22581) of Boston Scientific Corporation,
(3) Registration Statement (Form S-8 Nos. 333-25033, 333-25037, 333-36636, 333-61056, 333-61060, 333-76380, 333-98755, 333-111047, 333-131608, 333-133569, 333-134932, 333-151280, 333-174620, 333-174622, 333-188905, 333-196672, and 333-241022) of Boston Scientific Corporation;
of our reports dated February 23, 2021, with respect to the consolidated financial statements and schedule of Boston Scientific Corporation and the effectiveness of internal control over financial reporting of Boston Scientific Corporation included in this Annual Report (Form 10-K) of Boston Scientific Corporation for the year ended December 31, 2020.
/s/ Ernst & Young LLP
Boston, Massachusetts
February 23, 2021